Sign Up Today and Learn More About Biohm Technologies Stock
Invest in or calculate the value of your shares in Biohm Technologies or other pre-IPO companies through EquityZen's platform.

Biohm Technologies Stock
Biohm Technologies analyzes and manages the gut's total microbiome via consultations, tests, and consumer products.
About Biohm Technologies Stock
Founded
2016
Headquarters
Cleveland, OH, US
Industries
Software, Artificial Intelligence, Data and Analytics
Biohm Technologies Press Mentions
Stay in the know about the latest news on Biohm Technologies
Microbiome Sample Preparation Technology Market Research Report 2026 - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031
globenewswire • Jan 26, 2026
Inside Biohm’s new microbiome lab at Atlanta’s Science Square
rdworldonline • Nov 14, 2025
Biohm Technologies Expands Biotech R&D Footprint with New Lab Space at Portal Innovations in Atlanta
prweb • Nov 09, 2025
Human Microbiome Market Forecasts Report 2025-2030: Key Insights for Navigating Emerging Opportunities
globenewswire • Jun 21, 2025
Enterprise app startup Relish leads Northeast Ohio VC investments in Q1
bizjournals • Apr 15, 2025
Biohm Technologies Management
Leadership team at Biohm Technologies
CEO
Afif Ghannoum

Join now and verify your accreditation status to gain access to:
- Biohm Technologies Current Valuation
- Biohm Technologies Stock Price
- Biohm Technologies Management
- Available deals in Biohm Technologies and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Biohm Technologies Cap Table and Funding History by Share Class and Liquidity Preferences
- Biohm Technologies Revenue and Financials
- Biohm Technologies Highlights
- Biohm Technologies Business Model
- Biohm Technologies Risk Factors
- Biohm Technologies Research Report from SACRA Research
Trading Biohm Technologies Stock
How to invest in Biohm Technologies stock?
Accredited investors can buy pre-IPO stock in companies like Biohm Technologies through EquityZen funds. These investments are made available by existing Biohm Technologies shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell Biohm Technologies stock?
Shareholders can sell their Biohm Technologies stock through EquityZen's private company marketplace. EquityZen's network includes over 430K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 51K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."